"Where-there-is-no-psychiatrist Integrated Personal Therapy" Among Community-Dwelling Older Adults
8 giugno 2021 aggiornato da: Shefaly Shorey, National University, Singapore
"Where-there-is-no-psychiatrist Integrated Personal Therapy" Among Community-Dwelling Older Adults: Feasibility Randomized Controlled Trial
The World Health Organization (WHO) reported that approximately 15% of adults aged 60 and above suffer from some form of mental disorder, with one of the most common neuropsychiatric disorders being depression. Similar trends are seen in Singapore where 11.4% of the older adults aged 65 and above had depressive symptoms. Another population survey conducted among elderly in Singapore showed that elderly with subsyndromal depression (SSD) were similar to or worse than elderly with Major Depressive Disorder (MDD). However being a multi-ethnic Asia society the mental conditions such as depression and anxiety are seen as taboo topics to be discussed more so to seek help or treatment for these conditions in Singapore. Additionally scarcity of trained psychiatrists and work load of these trained professionals in the acute care settings make it difficult to reach these needy older adults. Hence, it is imperative to support the needs of this group of community dwelling older adults to ensure that their emotional wellbeing, and their condition do not progress to MDD. As such, this is the first of its kind study that will evaluate the effectiveness of solution focused brief therapy delivered by the lay mindfulness practitioner and the nurses.
If the pilot intervention is found to be feasible and effective, the large scale community trial will be planned to reach to more elderly in Singapore to help them age in a dignified way. In addition, other countries that do not involve lay mindfulness practitioners and nurses to provide integrated personal therapy in the community may benefit from this study as well.
Panoramica dello studio
Stato
Completato
Intervento / Trattamento
Tipo di studio
Interventistico
Iscrizione (Effettivo)
21
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
-
Singapore, Singapore, 117597
- National University of Singapore
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
Da 60 anni a 95 anni (Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
Inclusion Criteria:
- Community-dwelling older adults aged between 60-95 years old
- Able to understand and speak either English and/or Mandarin
- Able to attend at least 80% (five out of seven sessions) of the intervention sessions
- Have subsyndromal depression (obtained a score between one and five on the Geriatric Depression Scale) and/or subsyndromal anxiety (obtained a score between three and 10 on the Geriatric Anxiety Scale)
Exclusion Criteria:
- Older adults aged between 60-95 years old without subsyndromal depression and/or subsyndromal anxiety
- Older adults aged between 60-95 years old who could not understand or speak either English and/or Mandarin.
- Older adults aged between 60-95 years old who were unable to attend at least 80% (five out of seven sessions) of the intervention sessions.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Nessun intervento: Controllo
Nessun intervento
|
|
|
Sperimentale: Where-there-is-no-psychiatrist Integrated Personal Therapy (WIPT)
Solution-focused brief therapy (SFBT) involving psychoeducation and structured life review therapy, as well as mindfulness-based training
|
The WIPT include weekly face-to-face group sessions including mindfulness-based training and solution focused brief therapy (SFBT) involving psychoeducation and structured life review therapy catered to the personal needs of the participants.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Symptoms of depression
Lasso di tempo: Prior to start of intervention
|
Measured using Geriatric Depression Scale.
15-item scale where participants select either "Yes" or "No" in response to 15 statements.
The maximum score that could be obtained was 15 points; a high score on the scale indicates severe depressive symptoms.
|
Prior to start of intervention
|
|
Symptoms of depression
Lasso di tempo: 3 months post-recruitment
|
Measured using Geriatric Depression Scale.
15-item scale where participants select either "Yes" or "No" in response to 15 statements.
The maximum score that could be obtained was 15 points; a high score on the scale indicates severe depressive symptoms.
|
3 months post-recruitment
|
|
Symptoms of depression
Lasso di tempo: 6 months post-recruitment
|
Measured using Geriatric Depression Scale.
15-item scale where participants select either "Yes" or "No" in response to 15 statements.
The maximum score that could be obtained was 15 points; a high score on the scale indicates severe depressive symptoms.
|
6 months post-recruitment
|
|
Symptoms of anxiety
Lasso di tempo: Prior to start of intervention
|
Measured using Geriatric Anxiety Inventory.
20-item scale where participants select either "Agree" or "Disagree" to assess the anxiety symptoms in older adults.
The maximum score that could be obtained was 20 points; a high score indicates more anxiety symptoms.
|
Prior to start of intervention
|
|
Symptoms of anxiety
Lasso di tempo: 3 months post-recruitment
|
Measured using Geriatric Anxiety Inventory.
20-item scale where participants select either "Agree" or "Disagree" to assess the anxiety symptoms in older adults.
The maximum score that could be obtained was 20 points; a high score indicates more anxiety symptoms.
|
3 months post-recruitment
|
|
Symptoms of anxiety
Lasso di tempo: 6 months post-recruitment
|
Measured using Geriatric Anxiety Inventory.
20-item scale where participants select either "Agree" or "Disagree" to assess the anxiety symptoms in older adults.
The maximum score that could be obtained was 20 points; a high score indicates more anxiety symptoms.
|
6 months post-recruitment
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Life satisfaction
Lasso di tempo: Prior to start of intervention
|
Measured using Satisfaction with Life Scale.
5-item scale that included a 7-point Likert scale (1 = "Strongly Disagree"; 7 = "Strongly Agree").
The maximum score that could be obtained was 35 points; a high score indicates high level of satisfaction with life.
|
Prior to start of intervention
|
|
Life satisfaction
Lasso di tempo: 3 months post-recruitment
|
Measured using Satisfaction with Life Scale.
5-item scale that included a 7-point Likert scale (1 = "Strongly Disagree"; 7 = "Strongly Agree").
The maximum score that could be obtained was 35 points; a high score indicates high level of satisfaction with life.
|
3 months post-recruitment
|
|
Life satisfaction
Lasso di tempo: 6 months post-recruitment
|
Measured using Satisfaction with Life Scale.
5-item scale that included a 7-point Likert scale (1 = "Strongly Disagree"; 7 = "Strongly Agree").
The maximum score that could be obtained was 35 points; a high score indicates high level of satisfaction with life.
|
6 months post-recruitment
|
|
Social connectedness in terms of friendship
Lasso di tempo: Prior to start of intervention
|
Measured using Friendship Scale.
6-item where participants had to select an answer out of the five options (1 = "Not at All"; 5 = "Almost Always").
The maximum score that could be obtained was 30 points; a high score indicates high level of social connectedness.
|
Prior to start of intervention
|
|
Social connectedness in terms of friendship
Lasso di tempo: 3 months post-recruitment
|
Measured using Friendship Scale.
6-item where participants had to select an answer out of the five options (1 = "Not at All"; 5 = "Almost Always").
The maximum score that could be obtained was 30 points; a high score indicates high level of social connectedness.
|
3 months post-recruitment
|
|
Social connectedness in terms of friendship
Lasso di tempo: 6 months post-recruitment
|
Measured using Friendship Scale.
6-item where participants had to select an answer out of the five options (1 = "Not at All"; 5 = "Almost Always").
The maximum score that could be obtained was 30 points; a high score indicates high level of social connectedness.
|
6 months post-recruitment
|
|
Quality of life
Lasso di tempo: Prior to start of intervention
|
Measured using World Health Organization Quality of Life-Older Adults module.
13-item scale where participants had to select an answer based on a 5-point rating scale (1 = "Not at All"; 5 = "Very Satisfied").
The maximum score was 65 points, and a high score indicates high quality of life.
|
Prior to start of intervention
|
|
Quality of life
Lasso di tempo: 3 months post-recruitment
|
Measured using World Health Organization Quality of Life-Older Adults module.
13-item scale where participants had to select an answer based on a 5-point rating scale (1 = "Not at All"; 5 = "Very Satisfied").
The maximum score was 65 points, and a high score indicates high quality of life.
|
3 months post-recruitment
|
|
Quality of life
Lasso di tempo: 6 months post-recruitment
|
Measured using World Health Organization Quality of Life-Older Adults module.
13-item scale where participants had to select an answer based on a 5-point rating scale (1 = "Not at All"; 5 = "Very Satisfied").
The maximum score was 65 points, and a high score indicates high quality of life.
|
6 months post-recruitment
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Cortisol in ng/ml
Lasso di tempo: Prior to start of intervention
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
Prior to start of intervention
|
|
Cortisol in ng/ml
Lasso di tempo: 6 months post-recruitment
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
6 months post-recruitment
|
|
Annexin-A1 in ng/ml
Lasso di tempo: Prior to start of intervention
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
Prior to start of intervention
|
|
Annexin-A1 in ng/ml
Lasso di tempo: 6 months post-recruitment
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
6 months post-recruitment
|
|
Interleukin-1-beta in pg/ml
Lasso di tempo: Prior to start of intervention
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
Prior to start of intervention
|
|
Interleukin-1-beta in pg/ml
Lasso di tempo: 6 months post-recruitment
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
6 months post-recruitment
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
1 settembre 2019
Completamento primario (Effettivo)
31 gennaio 2020
Completamento dello studio (Effettivo)
31 marzo 2020
Date di iscrizione allo studio
Primo inviato
1 giugno 2021
Primo inviato che soddisfa i criteri di controllo qualità
8 giugno 2021
Primo Inserito (Effettivo)
15 giugno 2021
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
15 giugno 2021
Ultimo aggiornamento inviato che soddisfa i criteri QC
8 giugno 2021
Ultimo verificato
1 giugno 2021
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- A17-2003-B
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
No
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .